Autumn Glory Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Autumn Glory Partners's PFE Position: Q3 2026 in Review
Autumn Glory Partners increased its Pfizer (PFE) stake by 0.01% in Q3 2026, buying an estimated $239 and bringing the position to 66,221 shares worth $1.89M. The position accounts for 0.52% of the portfolio, ranked #50.
Autumn Glory Partners first reported a position in PFE in Q4 2021 and has held it in 17 quarters since. 2,002 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Autumn Glory Partners held 66,221 shares of Pfizer worth $1.89M as of Q3 2026.
- Autumn Glory Partners bought 9 Pfizer shares in Q3 2026, an estimated $239.
- Pfizer made up 0.52% of Autumn Glory Partners's portfolio in Q3 2026, its #50 holding.
- Autumn Glory Partners first reported a position in Pfizer in Q4 2021 and has held it in 17 quarters since.
- 2,002 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Autumn Glory Partners's 13F filing for Q3 2026, filed 26 Oct 2026.